Drug Profile
Research programme: cancer therapeutic and diagnostic - BioMetrx
Alternative Names: Rasstore™Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Georgetown University Medical Center
- Class Diagnostic agents
- Mechanism of Action RASSF1 protein stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in USA
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer(Diagnosis) in USA
- 25 Jan 2012 Preclinical trials in Cancer (diagnosis) in USA (unspecified route)